Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer

PURPOSE: Many women with hormone receptor-positive breast cancer discontinue effective aromatase inhibitor (AI) treatment due to joint symptoms. METHODS: We conducted a single-arm, open-label, phase II study evaluating glucosamine-sulfate (1,500 mg/day)+ chondroitin-sulfate (1,200 mg/day) for 24 wee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Greenlee, Heather, Crew, Katherine D., Shao, Theresa, Kranwinkel, Grace, Kalinsky, Kevin, Maurer, Matthew, Brafman, Lois, Insel, Beverly, Tsai, Wei Yann, Hershman, Dawn L
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3810608/
https://ncbi.nlm.nih.gov/pubmed/23111941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-012-1628-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados